Abstract
Advanced prostate cancers consistently display common features, i.e., progression to androgen resistance, rising prostate-specific antigen (PSA), and metastases to the skeleton. In this issue of Clinical Cancer Research , Nadiminty et al. report a provocative mechanistic link between PSA and bone
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have